Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$338.27 - $413.0 $144,103 - $175,938
426 Added 120.0%
781 $309,000
Q4 2023

Feb 01, 2024

SELL
$318.29 - $392.21 $103,444 - $127,468
-325 Reduced 47.79%
355 $125,000
Q3 2023

Nov 06, 2023

SELL
$354.9 - $412.41 $86,595 - $100,628
-244 Reduced 26.41%
680 $255,000
Q2 2023

Jul 07, 2023

BUY
$334.63 - $382.47 $166,645 - $190,470
498 Added 116.9%
924 $353,000
Q1 2023

May 10, 2023

BUY
$232.5 - $346.47 $43,942 - $65,482
189 Added 79.75%
426 $148,000
Q4 2022

Feb 06, 2023

SELL
$209.34 - $261.61 $111,787 - $139,699
-534 Reduced 69.26%
237 $56,000
Q2 2022

Aug 11, 2022

SELL
$280.61 - $420.45 $87,550 - $131,180
-312 Reduced 28.81%
771 $233,000
Q1 2022

May 12, 2022

SELL
$357.49 - $445.92 $225,933 - $281,821
-632 Reduced 36.85%
1,083 $444,000
Q4 2021

Feb 11, 2022

BUY
$402.25 - $471.34 $200,722 - $235,198
499 Added 41.04%
1,715 $806,000
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $116,163 - $149,910
320 Added 35.71%
1,216 $516,000
Q1 2021

May 13, 2021

SELL
$257.29 - $307.53 $59,691 - $71,346
-232 Reduced 20.57%
896 $252,000
Q4 2020

Feb 10, 2021

SELL
$261.16 - $301.66 $176,544 - $203,922
-676 Reduced 37.47%
1,128 $319,000
Q3 2020

Nov 04, 2020

BUY
$224.99 - $288.02 $189,216 - $242,224
841 Added 87.33%
1,804 $518,000
Q2 2020

Aug 12, 2020

SELL
$149.8 - $227.17 $19,623 - $29,759
-131 Reduced 11.97%
963 $216,000
Q1 2020

May 08, 2020

BUY
$128.96 - $174.76 $77,247 - $104,681
599 Added 121.01%
1,094 $167,000
Q3 2019

Nov 14, 2019

BUY
$121.41 - $150.02 $60,097 - $74,259
495 New
495 $70,000
Q4 2018

Feb 13, 2019

SELL
$93.0 - $123.98 $37,851 - $50,459
-407 Closed
0 $0
Q3 2018

Oct 31, 2018

BUY
$98.01 - $123.47 $39,890 - $50,252
407 New
407 $50,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Harvest Fund Management Co., LTD Portfolio

Follow Harvest Fund Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Fund Management Co., LTD with notifications on news.